The 12 Biomarkers Your Doctor Isn't Testing (But Should Be)

Summary

A standard annual blood panel typically checks total cholesterol, fasting glucose, and a basic metabolic panel. These tests are designed to detect existing disease — not to predict and prevent it. The 12 biomarkers covered in this article are the ones that show up abnormal 10–20 years before conventional labs detect a problem. Organized across three longevity systems — Metabolic Energy, Cardiovascular Flow, and Cellular Aging — these markers give you an early warning system that standard medicine largely ignores. Each marker includes the optimal range, what it means, and what to do if yours is out of range.

Why "Normal" Lab Results Aren't Enough

When your doctor says your results are "normal," they mean your results fall within the reference range — typically defined as the middle 95% of values in the tested population. In a population where 70% of adults are overweight or have at least one metabolic abnormality, "normal" is a low bar.

Fasting glucose "normal" ranges typically run to 99 mg/dL. But research from the Whitehall II study (Tabák et al., 2012, The Lancet) showed that glucose starts rising — and beta cell function starts declining — up to 13 years before a type 2 diabetes diagnosis. By the time fasting glucose crosses into the "abnormal" range, significant beta cell loss has already occurred.

The same pattern exists across cardiovascular, inflammatory, and cellular markers. Optimal ranges are not the same as "normal" ranges. What follows are the values associated with the lowest disease risk and the longest healthspan.

System 1: Metabolic Energy

Marker 1: Fasting Insulin

What it is: The amount of insulin circulating in your blood after an overnight fast. Insulin is the key that unlocks cells to absorb glucose — but when cells become resistant, the pancreas compensates by producing more.

Why it matters: Fasting insulin is the earliest detectable sign of insulin resistance, appearing years before fasting glucose or HbA1c becomes abnormal. Elevated fasting insulin is directly associated with visceral fat accumulation, hypertension, dyslipidemia, and cardiovascular disease.

Optimal range: 2–5 µIU/mL (microunits per milliliter) Conventional "normal" range: Under 25 µIU/mL (far too broad to be clinically useful)

A fasting insulin above 10 µIU/mL in the absence of diabetes should prompt serious lifestyle intervention. A landmark study in Circulation (Després et al., 1996) showed that men with fasting insulin above 10 µIU/mL had a 2.5-fold increased risk of coronary heart disease independent of other risk factors.

How to improve it: Intermittent fasting (12–16 hours), reduced refined carbohydrate intake, regular aerobic exercise, and weight loss targeting visceral fat. Fasting insulin is one of the most modifiable biomarkers in medicine.

Marker 2: HbA1c (Hemoglobin A1c)

What it is: A measure of average blood glucose over the past 2–3 months, expressed as a percentage of glycated hemoglobin.

Why it matters: HbA1c tracks cumulative glucose exposure, reflecting how often and how high blood sugar spikes. Chronic glucose elevation damages blood vessels, nerves, kidneys, and the retina through a process called advanced glycation end-product (AGE) formation.

Optimal range: 4.8–5.3% Conventional "normal" range: Under 5.7% (pre-diabetes starts at 5.7%)

Research from the New England Journal of Medicine (Selvin et al., 2010) showed that HbA1c of 5.5–6.0% was independently associated with increased risk of cardiovascular disease and diabetes — well within the "normal" range by conventional standards.

How to improve it: Reduce dietary refined carbohydrates and sugar, implement intermittent fasting, increase aerobic exercise (particularly post-meal walks), improve sleep quality, and reduce chronic stress through cortisol management.

Marker 3: Cortisol Rhythm

What it is: Cortisol follows a circadian rhythm — it should peak sharply within 30–45 minutes of waking (the Cortisol Awakening Response, or CAR) and decline steadily throughout the day, reaching its lowest point around midnight.

Why it matters: Cortisol is the master metabolic hormone. It mobilizes glucose, modulates inflammation, regulates immune function, and controls the sleep-wake cycle. A flat or inverted cortisol curve — high at night, low in the morning — is associated with metabolic syndrome, visceral fat accumulation, depression, chronic fatigue, and impaired immune function.

Optimal pattern: High AM (15–25 µg/dL at 8 AM), steadily declining, low PM (under 5 µg/dL at 4–8 PM), near-zero at midnight.

A 2006 study in Psychoneuroendocrinology (Kumari et al.) found that a blunted CAR was associated with increased risk of cardiovascular disease and metabolic syndrome.

How to assess it: 4-point salivary cortisol testing (morning, noon, afternoon, evening) — available through functional medicine labs. Standard blood cortisol testing done only once in the morning misses the entire rhythm.

How to improve it: Morning bright light exposure within 30 minutes of waking, morning exercise, consistent wake time, no caffeine within 8 hours of bedtime, evening breathwork and wind-down routines.

Marker 4: Waist-to-Height Ratio

What it is: Waist circumference divided by height. The simplest proxy for visceral fat without lab testing.

Optimal: Below 0.50 (waist circumference less than half your height)

Validated across 78 studies and 300,000+ participants as the single best anthropometric predictor of cardiometabolic risk (Ashwell et al., 2012, PLoS ONE). See our full article on visceral fat for detailed measurement protocols.

System 2: Cardiovascular Flow

Marker 5: ApoB (Apolipoprotein B)

What it is: ApoB is the primary protein on every atherogenic (artery-clogging) lipoprotein particle — including LDL, VLDL, IDL, and Lp(a). Every single one of these particles carries exactly one ApoB molecule, making ApoB a direct count of the total number of atherogenic particles in your blood.

Why it matters: LDL-cholesterol measures the amount of cholesterol carried inside LDL particles — not the number of particles. You can have normal LDL-C but a high number of small, dense LDL particles, each capable of penetrating arterial walls. ApoB captures this risk.

A 2019 consensus statement in the Journal of the American College of Cardiology (Sniderman et al.) concluded that ApoB is a superior measure to LDL-C for assessing cardiovascular risk and should be the primary lipid target for therapy.

Optimal range: Under 80 mg/dL (low risk); under 60 mg/dL (very low risk for high-risk individuals) Conventional "normal" range: Under 120 mg/dL (too permissive)

How to improve it: Reduce dietary saturated fat and refined carbohydrates, increase soluble fiber (psyllium husk, oats, legumes), aerobic exercise, weight loss targeting visceral fat, and omega-3 fatty acids. Statin therapy is first-line if lifestyle changes are insufficient.

Marker 6: Blood Pressure

What it is: The pressure exerted on artery walls during cardiac contraction (systolic) and relaxation (diastolic).

Optimal: Below 120/80 mmHg Hypertension stage 1: 130–139/80–89 mmHg (2017 ACC/AHA guidelines)

The landmark SPRINT trial (NEJM, 2015) demonstrated that targeting systolic blood pressure below 120 mmHg reduced cardiovascular events by 25% and all-cause mortality by 27% compared to the previous target of 140 mmHg.

How to improve it: Aerobic exercise (reduces systolic BP by an average of 5–8 mmHg), sodium reduction, increased dietary potassium (from vegetables and legumes), DASH diet pattern, nitric-oxide-boosting practices (nasal breathing, morning walks, beet juice), weight loss, stress reduction, and adequate sleep.

Marker 7: VO2 Max

What it is: The maximum rate of oxygen consumption during maximal exercise, expressed in mL/kg/min. VO2 max is the gold standard measure of cardiorespiratory fitness.

Why it matters: In a landmark study of 122,007 patients (Mandsager et al., 2018, JAMA Network Open), low cardiorespiratory fitness was associated with a higher mortality risk than smoking, hypertension, or diabetes. Moving from the "low" to "below average" fitness category was associated with a 23% reduction in mortality risk — a benefit exceeding most pharmaceutical interventions.

Age-adjusted optimal targets (mL/kg/min):

Age	Men (Good/Excellent)	Women (Good/Excellent)
30–39	Above 47 / Above 56	Above 41 / Above 50
40–49	Above 43 / Above 52	Above 37 / Above 46
50–59	Above 36 / Above 46	Above 32 / Above 40
60+	Above 30 / Above 40	Above 25 / Above 36

How to improve it: High-intensity interval training (HIIT) is the most efficient method — specifically the Norwegian 4×4 protocol (4 minutes at 90–95% maximum heart rate, 4 times, with 3-minute recovery periods) has been shown to increase VO2 max by 7–10% in 8 weeks (Wisløff et al., 2007, Circulation). Zone 2 training (conversational pace, 2–3 hours weekly) builds the aerobic base.

Marker 8: Resting Heart Rate

What it is: Heart rate measured at complete rest, ideally before getting out of bed in the morning.

Optimal range: 40–60 bpm (highly fit individuals may be in the 40s) Elevated risk: Above 80 bpm

A meta-analysis in the British Medical Journal (Zhang et al., 2016) including 45 cohort studies found that each 10 bpm increase in resting heart rate was associated with a 9% increase in all-cause mortality. Resting heart rate is a simple, cost-free indicator of autonomic nervous system health and cardiac efficiency.

How to improve it: Regular aerobic exercise (particularly zone 2 training), improved sleep quality, stress management, and reduced alcohol and caffeine intake.

System 3: Cellular Aging

Marker 9: Vitamin D, Magnesium, and Selenium

Vitamin D: Vitamin D deficiency (under 30 ng/mL) affects an estimated 40% of US adults (Forrest & Stuhldreher, 2011, Nutrition Research). Optimal range is 50–70 ng/mL. Low vitamin D is associated with increased all-cause mortality, impaired immune function, muscle weakness, depression, and insulin resistance. Morning sun exposure (15–30 minutes to large skin surface areas) is the most effective way to maintain levels. Supplementation with vitamin D3 (typically 2,000–5,000 IU daily with vitamin K2) is appropriate in deficient individuals.

Magnesium: Magnesium participates in over 300 enzymatic reactions including ATP production, protein synthesis, muscle function, and blood glucose control. Approximately 50% of US adults consume less than the recommended daily amount (Rosanoff et al., 2012, Nutrition Reviews). Optimal serum magnesium is 0.85–1.10 mmol/L. Low magnesium is independently associated with type 2 diabetes (RR 0.86 per 100 mg/day increment, Dong et al., 2011, Diabetes Care). Food sources include dark leafy greens, nuts, seeds, and legumes.

Selenium: Selenium is essential for thyroid hormone metabolism (converting T4 to active T3), antioxidant defense (as a component of glutathione peroxidase), and DNA repair. Optimal serum selenium is 120–150 µg/L. Brazil nuts (1–2 per day) provide approximately 70–90 µg of selenium each and are the most bioavailable dietary source.

Marker 10: hs-CRP (High-Sensitivity C-Reactive Protein)

What it is: C-reactive protein is produced by the liver in response to inflammation. The high-sensitivity version detects low-grade systemic inflammation not visible on standard CRP tests.

Optimal: Below 1.0 mg/L Elevated risk: Above 3.0 mg/L

The JUPITER trial (NEJM, 2008, Ridker et al.) enrolled 17,802 participants with normal LDL but elevated hs-CRP (above 2 mg/L). Statin therapy reduced cardiovascular events by 44% and all-cause mortality by 20% in this group — demonstrating that elevated hs-CRP is an independent, actionable cardiovascular risk factor.

How to reduce it: Anti-inflammatory dietary patterns (Mediterranean diet, omega-3 fatty acids, reduced ultra-processed foods and refined sugar), regular aerobic exercise, adequate sleep, smoking cessation, weight loss, and stress management.

Marker 11: HRV (Heart Rate Variability)

What it is: The variation in time between consecutive heartbeats. High HRV reflects a healthy, adaptive autonomic nervous system with strong parasympathetic (rest-and-digest) tone. Low HRV indicates chronic stress, poor recovery, or autonomic dysfunction.

Why it matters: HRV is a sensitive indicator of physiological resilience. A 2016 meta-analysis in the American Journal of Cardiology found that low HRV is independently associated with increased all-cause mortality and cardiovascular events.

Assessment: Modern wearables (Oura Ring, WHOOP, Apple Watch) measure HRV during sleep. Rather than a single number, the trend over time matters most — a rising weekly HRV average indicates improving recovery capacity.

How to improve it: Consistent sleep schedule, reduced alcohol (even moderate alcohol significantly suppresses HRV), cold exposure, breathwork (particularly slow resonant breathing at 4–6 breaths per minute), aerobic exercise, and stress management.

Marker 12: Muscle Mass and Grip Strength

What it is: Muscle mass (assessed by DEXA scan or bioimpedance) and grip strength (measured with a hand dynamometer) are proxies for overall musculoskeletal health and function.

Why it matters: Sarcopenia — age-related muscle loss — begins as early as the mid-30s at a rate of 3–8% per decade, accelerating after age 60 (Doherty, 2003, Journal of Applied Physiology). Low muscle mass is independently associated with insulin resistance (muscle is the primary site of glucose disposal), increased mortality, falls, and frailty.

Grip strength is one of the single strongest predictors of longevity. A study in The Lancet (Leong et al., 2015), following 139,691 participants across 17 countries, found that each 5 kg decrease in grip strength was associated with a 17% increased risk of cardiovascular mortality.

Optimal grip strength targets:

Men: 45–55 kg (dominant hand)
Women: 25–35 kg (dominant hand)

How to improve it: Resistance training 2–3 times weekly, adequate dietary protein (1.6–2.2 g/kg body weight daily), essential amino acid supplementation if needed, and minimizing sedentary time.

Getting These Tests

Most of these biomarkers are not included in standard annual panels. You can request them specifically from your physician or access them through functional medicine clinics and direct-to-consumer lab services. Tests like fasting insulin, ApoB, hs-CRP, and 4-point salivary cortisol are widely available.

Consider requesting these at your next physical, framing them as early prevention rather than diagnosis of existing disease.

Key Takeaways

"Normal" is not optimal: Standard reference ranges reflect population averages in an unhealthy population. Optimal ranges are defined by the lowest disease risk, not the median result.
Fasting insulin is your earliest metabolic warning: It rises years before fasting glucose or HbA1c becomes abnormal. Target under 5 µIU/mL.
ApoB replaces LDL-C: Particle count predicts cardiovascular risk better than cholesterol content. Target below 80 mg/dL.
VO2 max is the most powerful longevity predictor: Moving from low to average fitness reduces mortality more than most drug therapies.
HRV and resting heart rate reflect your recovery capacity: These are trainable biomarkers that improve with consistent lifestyle changes.
Muscle mass protects your metabolic health: Grip strength predicts longevity with remarkable consistency — strength training is non-negotiable.

References

Ashwell M, et al. Waist-to-height ratio is a better screening tool than waist circumference and BMI. PLoS ONE. 2012.
Desprès JP, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. NEJM. 1996;334(15):952–957.
Doherty TJ. Invited review: aging and sarcopenia. Journal of Applied Physiology. 2003;95(4):1717–1727.
Dong JY, et al. Magnesium intake and risk of type 2 diabetes. Diabetes Care. 2011;34(9):2116–2122.
Forrest KY, Stuhldreher WL. Prevalence and correlates of vitamin D deficiency in US adults. Nutrition Research. 2011;31(1):48–54.
Leong DP, et al. Prognostic value of grip strength. The Lancet. 2015;386(9990):266–273.
Mandsager K, et al. Association of cardiorespiratory fitness with long-term mortality. JAMA Network Open. 2018;1(6).
Ridker PM, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein (JUPITER). NEJM. 2008;359:2195–2207.
Selvin E, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. NEJM. 2010;362(9):800–811.
Sniderman AD, et al. ApoB versus non-HDL-C. Journal of the American College of Cardiology. 2019.
SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. NEJM. 2015;373(22):2103–2116.
Tabák AG, et al. Prediabetes: a high-risk state for diabetes development. The Lancet. 2012;379(9833):2279–2290.
Wisløff U, et al. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients. Circulation. 2007;115(24):3086–3094.
Zhang D, et al. Elevated resting heart rate and all-cause and cardiovascular mortality. Journal of the American College of Cardiology. 2016.

Metabolic Aide tracks all 12 biomarkers and builds a personalized action plan around your specific results. Get your free protocol.